The UAB Department of Radiation Oncology is pleased to announce the promotion of four faculty members, including three radiation oncologists and one medical physicist, effective Oct. 1, 2023.

One faculty member was also awarded tenure.

Please join us in congratulating these individuals and thanking them for their dedication to the department and to the UAB medical community. 

M. Chris Dobelbower, M.D., Ph.D. — Promoted to Professor, tenured, Radiation Oncology
Dobelbower is the Medical Director for Radiation Oncology at the Kirklin Clinic at Acton Road. He joined the department faculty in 2007 after graduating from the UAB Radiation Oncology Residency Program. He is the disease site leader for Lung cancers and his research interests include the treatment of thoracic malignancies including thoracic radiosurgery using fiducial-guided Stereotactic Body Radiation Therapy (SBRT), adaptive radiation and proton therapy.

Samuel Marcrom, M.D. — Promoted to Associate Professor, non-tenure, Radiation Oncology
Marcrom is Associate Medical Director of Brachytherapy, Associate Director of the UAB Radiation Oncology Residency Program, and Director of Medical Student Clerkship. He is an Associate Scientist at the Center for Clinical and Translational Science (CCTS). Marcrom joined the department faculty in 2020 and is a graduate of the UAB Radiation Oncology Residency Program. He is the disease site leader for Gynecological (GYN) cancers and his research is focused on clinical outcomes and educational program development.

Andrew McDonald, M.D, M.S. — Promoted to Associate Professor; Awarded tenure, Radiation Oncology
McDonald is Director of the UAB Radiation Oncology Residency Program and member of the UAB Institute for Cancer Outcomes and Survivorship. He is an Associate Scientist at the O'Neal Comprehensive Cancer Center at UAB and an Associate Scientist at the Center for Clinical and Translational Science (CCTS). He joined the department faculty in 2017 after completing the UAB Radiation Oncology Residency Program. He is the disease site leader for Genitourinary (GU) cancers and his research is focused on improving quality of life in cancer survivors and clinical trials.

Dennis N. Stanley, Ph.D. — Promoted to Associate Professor, non-tenure, Medical Physics
Stanley is Chief of Adaptive Therapy in the Department of Radiation Oncology. A Diplomate of the American Board of Radiology for Therapeutic Medical Physics (DABR), Stanley joined the department faculty in 2018 after graduating from the Medical Physics Residency Program at the University of Texas Health Science Center at San Antonio. His areas of interest are Adaptive Radiotherapy, Brachytherapy, Total Body Irradiation, and Special Procedures.